Review



yap1 inhibitor verteporfin  (MedChemExpress)


Bioz Verified Symbol MedChemExpress is a verified supplier
Bioz Manufacturer Symbol MedChemExpress manufactures this product  
  • Logo
  • About
  • News
  • Press Release
  • Team
  • Advisors
  • Partners
  • Contact
  • Bioz Stars
  • Bioz vStars
  • 98

    Structured Review

    MedChemExpress yap1 inhibitor verteporfin
    Yap1 Inhibitor Verteporfin, supplied by MedChemExpress, used in various techniques. Bioz Stars score: 98/100, based on 346 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/yap1+inhibitor+verteporfin/Verteporfin/pm42048035-93-7-14
    Average 98 stars, based on 346 article reviews
    yap1 inhibitor verteporfin - by Bioz Stars, 2026-09
    98/100 stars

    Images

    Related Articles

    Injection:

    Article Title: CXCL12/CXCR7/β-arrestin1 biased signal promotes epithelial-to-mesenchymal transition of colorectal cancer by repressing miRNAs through YAP1 nuclear translocation.
    Article Snippet: .. The mice injected with HCT116LV−CXCR7 cells were administered daily with YAP1 inhibitor Verteporfin (10 mg/kg, MedChemExpress LLC, USA) or solvent control. ..

    Article Title: CXCL12/CXCR7/β-arrestin1 biased signal promotes epithelial-to-mesenchymal transition of colorectal cancer by repressing miRNAs through YAP1 nuclear translocation.
    Article Snippet: To establish azoxymethane (AOM)/ dextran sodium sulfate (DSS)-induced inflammatory colonic adenocarcinoma, wild type C57BL/6 mice and Villin-CXCR7 mice (aged at 8 weeks, n = 5) were treated by a single intraperitoneal injection of AOM (10 mg/kg, Sigma, USA) and subsequent oral administration of 1% DSS (MP Biomedicals, USA) in drinking water ad libitum for 7 consecutive days and then returned to normal drinking for 14 days. .. VillinCXCR7 mice were injected intraperitoneally daily with YAP1 inhibitor Verteporfin (10 mg/kg, MedChemExpress LLC, USA) in the vehicle (40% PEG300, 5% Tween 80 and 45% normal saline) or vehicle control for 8 consecutive weeks. ..

    Article Title: CXCL12/CXCR7/β-arrestin1 biased signal promotes epithelial-to-mesenchymal transition of colorectal cancer by repressing miRNAs through YAP1 nuclear translocation
    Article Snippet: To establish azoxymethane (AOM)/ dextran sodium sulfate (DSS)-induced inflammatory colonic adenocarcinoma, wild type C57BL/6 mice and Villin-CXCR7 mice (aged at 8 weeks, n = 5) were treated by a single intraperitoneal injection of AOM (10 mg/kg, Sigma, USA) and subsequent oral administration of 1% DSS (MP Biomedicals, USA) in drinking water ad libitum for 7 consecutive days and then returned to normal drinking for 14 days. .. Villin-CXCR7 mice were injected intraperitoneally daily with YAP1 inhibitor Verteporfin (10 mg/kg, MedChemExpress LLC, USA) in the vehicle (40% PEG300, 5% Tween 80 and 45% normal saline) or vehicle control for 8 consecutive weeks. ..

    Article Title: CXCL12/CXCR7/β-arrestin1 biased signal promotes epithelial-to-mesenchymal transition of colorectal cancer by repressing miRNAs through YAP1 nuclear translocation
    Article Snippet: .. The mice injected with HCT116 LV−CXCR7 cells were administered daily with YAP1 inhibitor Verteporfin (10 mg/kg, MedChemExpress LLC, USA) or solvent control. ..

    Solvent:

    Article Title: CXCL12/CXCR7/β-arrestin1 biased signal promotes epithelial-to-mesenchymal transition of colorectal cancer by repressing miRNAs through YAP1 nuclear translocation.
    Article Snippet: .. The mice injected with HCT116LV−CXCR7 cells were administered daily with YAP1 inhibitor Verteporfin (10 mg/kg, MedChemExpress LLC, USA) or solvent control. ..

    Article Title: CXCL12/CXCR7/β-arrestin1 biased signal promotes epithelial-to-mesenchymal transition of colorectal cancer by repressing miRNAs through YAP1 nuclear translocation
    Article Snippet: .. The mice injected with HCT116 LV−CXCR7 cells were administered daily with YAP1 inhibitor Verteporfin (10 mg/kg, MedChemExpress LLC, USA) or solvent control. ..

    Control:

    Article Title: CXCL12/CXCR7/β-arrestin1 biased signal promotes epithelial-to-mesenchymal transition of colorectal cancer by repressing miRNAs through YAP1 nuclear translocation.
    Article Snippet: .. The mice injected with HCT116LV−CXCR7 cells were administered daily with YAP1 inhibitor Verteporfin (10 mg/kg, MedChemExpress LLC, USA) or solvent control. ..

    Article Title: CXCL12/CXCR7/β-arrestin1 biased signal promotes epithelial-to-mesenchymal transition of colorectal cancer by repressing miRNAs through YAP1 nuclear translocation.
    Article Snippet: To establish azoxymethane (AOM)/ dextran sodium sulfate (DSS)-induced inflammatory colonic adenocarcinoma, wild type C57BL/6 mice and Villin-CXCR7 mice (aged at 8 weeks, n = 5) were treated by a single intraperitoneal injection of AOM (10 mg/kg, Sigma, USA) and subsequent oral administration of 1% DSS (MP Biomedicals, USA) in drinking water ad libitum for 7 consecutive days and then returned to normal drinking for 14 days. .. VillinCXCR7 mice were injected intraperitoneally daily with YAP1 inhibitor Verteporfin (10 mg/kg, MedChemExpress LLC, USA) in the vehicle (40% PEG300, 5% Tween 80 and 45% normal saline) or vehicle control for 8 consecutive weeks. ..

    Article Title: CXCL12/CXCR7/β-arrestin1 biased signal promotes epithelial-to-mesenchymal transition of colorectal cancer by repressing miRNAs through YAP1 nuclear translocation
    Article Snippet: To establish azoxymethane (AOM)/ dextran sodium sulfate (DSS)-induced inflammatory colonic adenocarcinoma, wild type C57BL/6 mice and Villin-CXCR7 mice (aged at 8 weeks, n = 5) were treated by a single intraperitoneal injection of AOM (10 mg/kg, Sigma, USA) and subsequent oral administration of 1% DSS (MP Biomedicals, USA) in drinking water ad libitum for 7 consecutive days and then returned to normal drinking for 14 days. .. Villin-CXCR7 mice were injected intraperitoneally daily with YAP1 inhibitor Verteporfin (10 mg/kg, MedChemExpress LLC, USA) in the vehicle (40% PEG300, 5% Tween 80 and 45% normal saline) or vehicle control for 8 consecutive weeks. ..

    Article Title: CXCL12/CXCR7/β-arrestin1 biased signal promotes epithelial-to-mesenchymal transition of colorectal cancer by repressing miRNAs through YAP1 nuclear translocation
    Article Snippet: .. The mice injected with HCT116 LV−CXCR7 cells were administered daily with YAP1 inhibitor Verteporfin (10 mg/kg, MedChemExpress LLC, USA) or solvent control. ..

    Saline:

    Article Title: CXCL12/CXCR7/β-arrestin1 biased signal promotes epithelial-to-mesenchymal transition of colorectal cancer by repressing miRNAs through YAP1 nuclear translocation.
    Article Snippet: To establish azoxymethane (AOM)/ dextran sodium sulfate (DSS)-induced inflammatory colonic adenocarcinoma, wild type C57BL/6 mice and Villin-CXCR7 mice (aged at 8 weeks, n = 5) were treated by a single intraperitoneal injection of AOM (10 mg/kg, Sigma, USA) and subsequent oral administration of 1% DSS (MP Biomedicals, USA) in drinking water ad libitum for 7 consecutive days and then returned to normal drinking for 14 days. .. VillinCXCR7 mice were injected intraperitoneally daily with YAP1 inhibitor Verteporfin (10 mg/kg, MedChemExpress LLC, USA) in the vehicle (40% PEG300, 5% Tween 80 and 45% normal saline) or vehicle control for 8 consecutive weeks. ..

    Article Title: CXCL12/CXCR7/β-arrestin1 biased signal promotes epithelial-to-mesenchymal transition of colorectal cancer by repressing miRNAs through YAP1 nuclear translocation
    Article Snippet: To establish azoxymethane (AOM)/ dextran sodium sulfate (DSS)-induced inflammatory colonic adenocarcinoma, wild type C57BL/6 mice and Villin-CXCR7 mice (aged at 8 weeks, n = 5) were treated by a single intraperitoneal injection of AOM (10 mg/kg, Sigma, USA) and subsequent oral administration of 1% DSS (MP Biomedicals, USA) in drinking water ad libitum for 7 consecutive days and then returned to normal drinking for 14 days. .. Villin-CXCR7 mice were injected intraperitoneally daily with YAP1 inhibitor Verteporfin (10 mg/kg, MedChemExpress LLC, USA) in the vehicle (40% PEG300, 5% Tween 80 and 45% normal saline) or vehicle control for 8 consecutive weeks. ..

    Transfection:

    Article Title: HIRA promotes osteogenic differentiation of BMSCs and ameliorates osteoporosis by mediating M2 polarization of macrophages through the YAP1/β-catenin pathway.
    Article Snippet: Extended author information available on the last page of the article Abstract Impaired macrophage polarization is a key factor exacerbating osteoporosis (OP), influencing bone metabolism via modulating the osteogenic differentiation of bone marrow mesenchymal stem cells (BMSCs).. Histone cell cycle regulator (HIRA), an epigenetic regulator, is downregulated in OP.. However, its role in modulating macrophage polarization and BMSCs osteogenic differentiation remains unclear.

    Concentration Assay:

    Article Title: LH promotes testosterone synthesis in rooster leydig cells through YAP1/ACSL4/SOAT1 pathway.
    Article Snippet: Testosterone synthesis in Leydig cells requires precise coordination between LH signaling and cholesterol metabolism, but the mechanisms underlying this regulation remain incompletely understood.. In this study, we reveal a previously unrecognized YAP1-ACSL4 axis essential for LH-induced testosterone production by integrating transcriptomic profiling and functional studies in Leydig cells.. Transcriptomic sequencing identified ACSL4 and YAP1 as key regulators of testosterone synthesis induced by LH.



    Similar Products

    98
    MedChemExpress yap1 inhibitor verteporfin
    Yap1 Inhibitor Verteporfin, supplied by MedChemExpress, used in various techniques. Bioz Stars score: 98/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/yap1+inhibitor+verteporfin/Verteporfin/pm42048035-93-7-14
    Average 98 stars, based on 1 article reviews
    yap1 inhibitor verteporfin - by Bioz Stars, 2026-09
    98/100 stars
      Buy from Supplier

    94
    TargetMol yap1 inhibitor verteporfin
    Yap1 Inhibitor Verteporfin, supplied by TargetMol, used in various techniques. Bioz Stars score: 94/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/yap1+inhibitor+verteporfin/Verteporfin/pm41871675-72-8-13
    Average 94 stars, based on 1 article reviews
    yap1 inhibitor verteporfin - by Bioz Stars, 2026-09
    94/100 stars
      Buy from Supplier

    95
    Tocris yap1 inhibitor cat no 5305
    Yap1 Inhibitor Cat No 5305, supplied by Tocris, used in various techniques. Bioz Stars score: 95/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/yap1+inhibitor+verteporfin/Verteporfin/pm38943285-59-23-28
    Average 95 stars, based on 1 article reviews
    yap1 inhibitor cat no 5305 - by Bioz Stars, 2026-09
    95/100 stars
      Buy from Supplier

    90
    Tocris verteporfin, a yap1 inhibitor
    Verteporfin, A Yap1 Inhibitor, supplied by Tocris, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/yap1+inhibitor+verteporfin/verteporfin++a+yap1+inhibitor/pm38943285-59-21-28
    Average 90 stars, based on 1 article reviews
    verteporfin, a yap1 inhibitor - by Bioz Stars, 2026-09
    90/100 stars
      Buy from Supplier

    90
    Millipore verteporfin (yap1 inhibitor
    Verteporfin (Yap1 Inhibitor, supplied by Millipore, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/yap1+inhibitor+verteporfin/verteporfin/10__21203_slash_rs__3__rs___3936782_slash_v1-56-13-22
    Average 90 stars, based on 1 article reviews
    verteporfin (yap1 inhibitor - by Bioz Stars, 2026-09
    90/100 stars
      Buy from Supplier

    95
    Selleck Chemicals yap1 inhibitor
    Fig. 1. Elevated hepatic expression of <t>YAP1</t> during liver regeneration. (A). Histological changes, Ki67 staining, and PCNA staining in pre-PHx and PHx-24 h groups. 10X scale bar: 250 mm, 40X scale bar: 50 mm. (BeC). Protein expression levels of YAP1 in pre-PHx and PHx-24 h groups. ***P < 0.001. (D). Serum levels of ALB in pre-PHx and PHx-24 h groups. ***P < 0.001. (E). Immunocytofluorescense staining of hepatic ALB in pre-PHx and PHx-24 h groups. pre-PHx: before partial hepatectomy, PHx-24 h: 24 h post partial hepatectomy, HE: hematoxylin-eosin staining, PCNA: proliferating cell nuclear antigen, YAP1: yes-associated protein 1, ALB: albumin.
    Yap1 Inhibitor, supplied by Selleck Chemicals, used in various techniques. Bioz Stars score: 95/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/yap1+inhibitor+verteporfin/Verteporfin/pm37534236-58-2-7
    Average 95 stars, based on 1 article reviews
    yap1 inhibitor - by Bioz Stars, 2026-09
    95/100 stars
      Buy from Supplier

    Image Search Results


    Fig. 1. Elevated hepatic expression of YAP1 during liver regeneration. (A). Histological changes, Ki67 staining, and PCNA staining in pre-PHx and PHx-24 h groups. 10X scale bar: 250 mm, 40X scale bar: 50 mm. (BeC). Protein expression levels of YAP1 in pre-PHx and PHx-24 h groups. ***P < 0.001. (D). Serum levels of ALB in pre-PHx and PHx-24 h groups. ***P < 0.001. (E). Immunocytofluorescense staining of hepatic ALB in pre-PHx and PHx-24 h groups. pre-PHx: before partial hepatectomy, PHx-24 h: 24 h post partial hepatectomy, HE: hematoxylin-eosin staining, PCNA: proliferating cell nuclear antigen, YAP1: yes-associated protein 1, ALB: albumin.

    Journal: Regenerative therapy

    Article Title: Transcriptomic analysis of hepatocytes reveals the association between ubiquitin-specific peptidase 1 and yes-associated protein 1 during liver regeneration.

    doi: 10.1016/j.reth.2023.07.004

    Figure Lengend Snippet: Fig. 1. Elevated hepatic expression of YAP1 during liver regeneration. (A). Histological changes, Ki67 staining, and PCNA staining in pre-PHx and PHx-24 h groups. 10X scale bar: 250 mm, 40X scale bar: 50 mm. (BeC). Protein expression levels of YAP1 in pre-PHx and PHx-24 h groups. ***P < 0.001. (D). Serum levels of ALB in pre-PHx and PHx-24 h groups. ***P < 0.001. (E). Immunocytofluorescense staining of hepatic ALB in pre-PHx and PHx-24 h groups. pre-PHx: before partial hepatectomy, PHx-24 h: 24 h post partial hepatectomy, HE: hematoxylin-eosin staining, PCNA: proliferating cell nuclear antigen, YAP1: yes-associated protein 1, ALB: albumin.

    Article Snippet: Verteporfin, a YAP1 inhibitor, was acquired from Selleck (Selleck, USA).

    Techniques: Expressing, Staining

    Fig. 2. Targeting YAP1 impairs hepatocyte proliferation. (A). Immunocytofluorescense staining of YAP1 in pre-PHx-Hep and PHx-24 h-Hep groups. Enlargement: 40X. (B). Whole, cytoplasma and nucleus expression of YAP1 and PCNA in pre-PHx-Hep and PHx-24 h-Hep groups. (C). siRNA transfection in PHx-24 h-Hep cells. Enlargement: 40X. (DeE). siRNA transfection decreased the expressions of YAP1, Cyclin D1 and PCNA in PHx-24 h-Hep cells. *P < 0.05, **P < 0.01, ***P < 0.001. (FeH). Expression of YAP1 in Vehicle and Verteporfin treated BRL3A cells. **P < 0.01. (GeJ). Expression of Cyclin D1 and PCNA in Vehicle and Verteporfin treated BRL3A cells. *P < 0.05, **P < 0.01. (K). The cell proliferation of BRL3A in Vehicle and Verteporfin treated BRL3A cells. *P < 0.05.

    Journal: Regenerative therapy

    Article Title: Transcriptomic analysis of hepatocytes reveals the association between ubiquitin-specific peptidase 1 and yes-associated protein 1 during liver regeneration.

    doi: 10.1016/j.reth.2023.07.004

    Figure Lengend Snippet: Fig. 2. Targeting YAP1 impairs hepatocyte proliferation. (A). Immunocytofluorescense staining of YAP1 in pre-PHx-Hep and PHx-24 h-Hep groups. Enlargement: 40X. (B). Whole, cytoplasma and nucleus expression of YAP1 and PCNA in pre-PHx-Hep and PHx-24 h-Hep groups. (C). siRNA transfection in PHx-24 h-Hep cells. Enlargement: 40X. (DeE). siRNA transfection decreased the expressions of YAP1, Cyclin D1 and PCNA in PHx-24 h-Hep cells. *P < 0.05, **P < 0.01, ***P < 0.001. (FeH). Expression of YAP1 in Vehicle and Verteporfin treated BRL3A cells. **P < 0.01. (GeJ). Expression of Cyclin D1 and PCNA in Vehicle and Verteporfin treated BRL3A cells. *P < 0.05, **P < 0.01. (K). The cell proliferation of BRL3A in Vehicle and Verteporfin treated BRL3A cells. *P < 0.05.

    Article Snippet: Verteporfin, a YAP1 inhibitor, was acquired from Selleck (Selleck, USA).

    Techniques: Staining, Expressing, Transfection

    Fig. 3. Identification of the association between USP1 and YAP1 in hepatocyte proliferation. (A). Volcano Plot of differentially expressed genes between the pre-PHx-Hep group and the PHx-24h-Hep group. (B). Heatmap of differentially expressed genes that were up-regulated in the PHx-24h-Hep group. (C). Volcano Plot of differentially expressed genes that were correlated with YAP1 in the liver hepatocellular carcinoma (LIHC) dataset. (D). Heatmap of the top 50 differentially expressed genes that were positively correlated with YAP1 in the LIHC dataset. (E). Venn results showed the common genes between the YAP1 related genes and the DEG1. (F). PPI network of the identified 119 genes, hub genes were showed in red color. (G). Heatmap of the identified hub genes. (H). KEGG analysis of the identified hub genes. (I). Expression of USP1 in pre-PHx-Hep and PHx-24h-Hep groups.

    Journal: Regenerative therapy

    Article Title: Transcriptomic analysis of hepatocytes reveals the association between ubiquitin-specific peptidase 1 and yes-associated protein 1 during liver regeneration.

    doi: 10.1016/j.reth.2023.07.004

    Figure Lengend Snippet: Fig. 3. Identification of the association between USP1 and YAP1 in hepatocyte proliferation. (A). Volcano Plot of differentially expressed genes between the pre-PHx-Hep group and the PHx-24h-Hep group. (B). Heatmap of differentially expressed genes that were up-regulated in the PHx-24h-Hep group. (C). Volcano Plot of differentially expressed genes that were correlated with YAP1 in the liver hepatocellular carcinoma (LIHC) dataset. (D). Heatmap of the top 50 differentially expressed genes that were positively correlated with YAP1 in the LIHC dataset. (E). Venn results showed the common genes between the YAP1 related genes and the DEG1. (F). PPI network of the identified 119 genes, hub genes were showed in red color. (G). Heatmap of the identified hub genes. (H). KEGG analysis of the identified hub genes. (I). Expression of USP1 in pre-PHx-Hep and PHx-24h-Hep groups.

    Article Snippet: Verteporfin, a YAP1 inhibitor, was acquired from Selleck (Selleck, USA).

    Techniques: Expressing

    Fig. 4. Overexpression of YAP1 rescues the impairment of hepatocyte proliferation induced by ML-323. (A). GeneMina results showed the interactions among USP1 and YAP1, Cyclin D1, PCNA. (BeD). Correlation analysis between USP1 and YAP1, Cyclin D1, PCNA. (E). Protein expression of YAP1, Cyclin D1 and PCNA in Ctrl and ML-323 treated BRL3A cells. (F). Lenti-virus infection in BRL3A cells with different MOI. Enlargement: 40X. (GeH). Expression of YAP1 in Control and YAP1 overexpressed BRL3A cells. **P < 0.01. (IeK). Protein expression of YAP1 and PCNA in different groups. *P < 0.05, **P < 0.01, ***P < 0.0001.

    Journal: Regenerative therapy

    Article Title: Transcriptomic analysis of hepatocytes reveals the association between ubiquitin-specific peptidase 1 and yes-associated protein 1 during liver regeneration.

    doi: 10.1016/j.reth.2023.07.004

    Figure Lengend Snippet: Fig. 4. Overexpression of YAP1 rescues the impairment of hepatocyte proliferation induced by ML-323. (A). GeneMina results showed the interactions among USP1 and YAP1, Cyclin D1, PCNA. (BeD). Correlation analysis between USP1 and YAP1, Cyclin D1, PCNA. (E). Protein expression of YAP1, Cyclin D1 and PCNA in Ctrl and ML-323 treated BRL3A cells. (F). Lenti-virus infection in BRL3A cells with different MOI. Enlargement: 40X. (GeH). Expression of YAP1 in Control and YAP1 overexpressed BRL3A cells. **P < 0.01. (IeK). Protein expression of YAP1 and PCNA in different groups. *P < 0.05, **P < 0.01, ***P < 0.0001.

    Article Snippet: Verteporfin, a YAP1 inhibitor, was acquired from Selleck (Selleck, USA).

    Techniques: Over Expression, Expressing, Virus, Infection, Control

    Fig. 6. Potential relationships between USP1 and YAP1 induced hepatocyte proliferation during liver regeneration. PHx: partial hepatectomy, USP1: ubiquitin specific peptidase 1, YAP1: yes-associated protein 1, PCNA: proliferating cell nuclear antigen.

    Journal: Regenerative therapy

    Article Title: Transcriptomic analysis of hepatocytes reveals the association between ubiquitin-specific peptidase 1 and yes-associated protein 1 during liver regeneration.

    doi: 10.1016/j.reth.2023.07.004

    Figure Lengend Snippet: Fig. 6. Potential relationships between USP1 and YAP1 induced hepatocyte proliferation during liver regeneration. PHx: partial hepatectomy, USP1: ubiquitin specific peptidase 1, YAP1: yes-associated protein 1, PCNA: proliferating cell nuclear antigen.

    Article Snippet: Verteporfin, a YAP1 inhibitor, was acquired from Selleck (Selleck, USA).

    Techniques: Ubiquitin Proteomics